A recent executive forum in Los Angeles brought together leaders from healthcare, litigation, and risk management to discuss the challenges and opportunities presented by rapid technological advancement, economic uncertainty, and legal complexity in American business. The event featured Brian Hegarty, president of Marsh McLennan Agency’s Los Angeles office, who moderated a conversation with Dr. Ara J. Baghdasarian, CEO of Southern California Medical Center (SCMC), and Jordan Grotzinger, co-chair of Greenberg Traurig’s Los Angeles Litigation Practice.

Throughout the discussion, artificial intelligence (AI) emerged as a central theme, characterized not as a distant prospect but a present force actively reshaping operational and risk frameworks. Dr. Baghdasarian underscored the speed at which AI is transforming industries, cautioning that many executives are unprepared for the rapid pace of change. He stressed the importance of proactive leadership, asserting that organizations that adapt and leverage AI proactively will outperform those that remain reactive.

From a legal standpoint, Grotzinger highlighted the new liabilities introduced by AI, particularly concerning intellectual property rights and the protection of trade secrets. While recognizing AI as a powerful tool that can enhance efficiency, he emphasized that it cannot substitute for careful human oversight. Without such diligence, companies face substantial reputational risks and potential legal repercussions.

Panelists also explored broader operational complexities arising from regulatory and economic pressures. Dr. Baghdasarian discussed how rising healthcare costs, often viewed narrowly as human resources expenses, actually represent deeper systemic weaknesses. He noted that limited access to healthcare coverage leads patients to delay treatment, ultimately resulting in costlier emergency care. This dynamic imposes a significant strain on both healthcare providers and businesses that must manage employee health.

Regarding accountability for navigating these uncertain environments, Dr. Baghdasarian highlighted the critical role of leadership in steering organizations through shifting policy landscapes and financial challenges. He suggested that effective governance and strategic foresight are key to mitigating the risks posed by evolving regulations and cost structures.

The forum provided a multi-dimensional examination of how technological innovation, legal frameworks, and economic factors are converging to reshape the American business landscape. The insights offered by healthcare and legal experts emphasized the necessity for business leaders to engage with these changes actively and thoughtfully to maintain competitive advantages and ensure operational resilience.